Log in to your Inderes Free account to see all free content on this page.
ODI Pharma
3.88 SEK
-0.51 %
Less than 1K followers
ODI
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.51 %
+2.11 %
+11.49 %
-10.19 %
+280.39 %
+113.19 %
-18.68 %
-20.51 %
-65.45 %
ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are made through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. Operations are found within the European market, with the headquarters in Stockholm.
Read moreMarket cap
71.12M SEK
Turnover
2.68K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.5.
2026
Interim report Q3'26
27.8.
2026
Annual report '26
All
Press releases
ShowingAll content types
ODI Pharma issues a reverse profit warning following improved revenue development
Notice to Annual General Meeting in ODI Pharma AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio